Association of neuropathy, sarcopenia and physical function in acute lymphoblastic leukemia survivors with chemotherapy alone

Read full text Summarise with VIRAT
Authors: Martin Kaj Fridh, Mengqi Xing, Sedigheh Mirzaei, David Mizrahi, Hanne Bækgaard Larsen, Stephanie B. Dixon, Nicholas Steve Phillips, Kevin R. Krull, Hiroto Inaba, Ching‐Hon Pui, Seth E. Karol, Angela M. Delaney
+3 more Sue Creviston Kaste, Melissa Maria Hudson, Kirsten K. Ness
Cited by: 0
References: 70

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

BACKGROUND: Despite excellent survival and elimination of cranial radiation, patients treated for acute lymphoblastic leukemia (ALL) in childhood remain at increased risk for chronic conditions, including peripheral neuropathy and sarcopenia. This study aimed to evaluate the association between peripheral neuropathy and sarcopenia in survivors of childhood ALL without prior cranial radiation exposure. Additionally, we explore the effects of neuropathy and sarcopenia on physical function and exercise behavior. METHODS: We included survivors of childhood ALL diagnosed between 1962 and 2012, aged ≥18 years without a history of cranial radiation from the St. Jude Lifetime Cohort Study (SJLIFE). Peripheral neuropathy was assessed using the Modified Total Neuropathy Score (mTNS). Sarcopenia was defined by low muscle mass (dual X-ray absorptiometry) and muscle weakness, with muscle strength assessed using hand grip and quadriceps strength tests. Physical function was evaluated with the Timed-Up-and-Go test and a 50-foot walk test. Physical activity was self-reported via the NHANES Physical Activity Questionnaire. Statistical analyses, including modified Poisson regression, were performed to examine associations. RESULTS: Among 537 survivors (median age: 28 years, range 18-52), 31.7% had peripheral neuropathy, 19.0% had reduced muscle strength, and 21.6% had reduced relative lean muscle mass. Neuropathy was significantly associated with impaired gait speed (RR: 1.31, 95% CI 1.01 to 1.7). Sarcopenia, particularly impaired muscle strength, was associated with impaired mobility (RR: 2.99, 95% CI 1.91 to 4.68), gait speed (RR: 1.45, 95% CI 1.06 to 1.97), and

Fields of Study & Subjects

Childhood Cancer Survivors' Quality of Life Acute Lymphoblastic Leukemia research Cancer survivorship and care

Publication details

Journal / source
Journal of Cancer Survivorship
Volume
20
Issue
S2
Pages
1767–1778
Publication date
26 March 2026
Language
EN